Moderna is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines. In more than 10 years since its inception, Moderna has transformed from a research-stage company advancing programs in the field of mRNA, to an enterprise with respiratory vaccines as well as a diverse portfolio of vaccine and therapy candidates across seven modalities.
Moderna’s vaccines are distributed through AAP’s Primary Wholesaler and authorized distributors FFF Enterprises, InSource and Moderna Direct (ModernaDirect.com).